Table of Contents

Chapter 1 Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Application
1.1.3. End-use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application
2.2.3. End-use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Deep Brain Stimulation Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing incidences of neurological diseases
3.2.1.2. Technological advancement in devices
3.2.1.3. Increasing preference for targeted therapy approach
3.2.2. Market restraint analysis
3.2.2.1. Complex regulatory framework
3.2.2.2. Risks of DBS surgery
3.3. Deep Brain Stimulation Devices Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.3. Covid-19 Impact Analysis
Chapter 4. Deep Brain Stimulation Devices Market: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Single Channel
4.1.2. Dual Channel
4.2. Product Market Share, 2018 & 2030
4.3. Segment Dashboard
4.4. Global Deep Brain Stimulation Devices Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
4.5.1. Single Channel
4.5.1.1. Single channel market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Dual Channel
4.5.2.1. Dual channel market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Deep Brain Stimulation Devices Market: Application Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Pain Management
5.1.2. Epilepsy
5.1.3. Essential Tremor
5.1.4. Obsessive Compulsive Disorder (OCD)
5.1.5. Parkinson’s Disease
5.1.6. Depression
5.1.7. Dystonia
5.1.8. Others
5.2. Application Market Share, 2018 & 2030
5.3. Segment Dashboard
5.4. Global Deep Brain Stimulation Devices Market by Application Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
5.5.1. Pain Management
5.5.1.1. Pain management market estimates and forecast 2018 to 2030 (USD Million)
5.5.2. Epilepsy
5.5.2.1. Epilepsy market estimates and forecast 2018 to 2030 (USD Million)
5.5.3. Essential Tremor
5.5.3.1. Essential tremor market estimates and forecast 2018 to 2030 (USD Million)
5.5.4. Obsessive Compulsive Disorder (OCD)
5.5.4.1. Obsessive Compulsive Disorder (OCD) market estimates and forecast 2018 to 2030 (USD Million)
5.5.5. Parkinson’s Disease
5.5.5.1. Parkinson’s disease market estimates and forecast 2018 to 2030 (USD Million)
5.5.6. Depression
5.5.6.1. Depression market estimates and forecast 2018 to 2030 (USD Million)
5.5.7. Dystonia
5.5.7.1. Dystonia market estimates and forecast 2018 to 2030 (USD Million)
5.5.8. Others
5.5.8.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Deep Brain Stimulation Devices Market: End-use Estimates & Trend Analysis
6.1. Definitions and Scope
6.1.1. Hospitals & Clinics
6.1.2. Homecare
6.1.3. Others
6.2. End-use Market Share, 2018 & 2030
6.3. Segment Dashboard
6.4. Global Deep Brain Stimulation Devices by End Use Outlook
6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
6.5.1. Hospitals
6.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
6.5.2. Neurology Clinics
6.5.2.1. Neurology clinics market estimates and forecast 2018 to 2030 (USD Million)
6.5.3. Ambulatory Surgical Centers
6.5.3.1. Ambulatory surgical centers market estimates and forecast 2018 to 2030 (USD Million)
6.5.4. Research Centers
6.5.4.1. Research centers market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Deep Brain Stimulation Devices Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2018 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2023 to 2030
7.5. North America
7.5.1. U.S.
7.5.1.1. U.S. market estimates and forecast, 2018 – 2030 (USD Million)
7.5.2. Canada
7.5.2.1. Canada market estimates and forecast, 2018 – 2030 (USD Million)
7.6. Europe
7.6.1. UK
7.6.1.1. UK market estimates and forecast, 2018 – 2030 (USD Million)
7.6.2. Germany
7.6.2.1. Germany market estimates and forecast, 2018 – 2030 (USD Million)
7.6.3. France
7.6.3.1. France market estimates and forecast, 2018 – 2030 (USD Million)
7.6.4. Italy
7.6.4.1. Italy market estimates and forecast, 2018 – 2030 (USD Million)
7.6.5. Spain
7.6.5.1. Spain market estimates and forecast, 2018 – 2030 (USD Million)
7.6.6. Norway
7.6.6.1. Norway market estimates and forecast, 2018 – 2030 (USD Million)
7.6.7. Sweden
7.6.7.1. Sweden market estimates and forecast, 2018 – 2030 (USD Million)
7.6.8. Denmark
7.6.8.1. Denmark market estimates and forecast, 2018 – 2030 (USD Million)
7.7. Asia Pacific
7.7.1. Japan
7.7.1.1. Japan market estimates and forecast, 2018 – 2030 (USD Million)
7.7.2. China
7.7.2.1. China market estimates and forecast, 2018 – 2030 (USD Million)
7.7.3. India
7.7.3.1. India market estimates and forecast, 2018 – 2030 (USD Million)
7.7.4. Australia
7.7.4.1. Australia market estimates and forecast, 2018 – 2030 (USD Million)
7.7.5. South Korea
7.7.5.1. South Korea market estimates and forecast, 2018 – 2030 (USD Million)
7.7.6. Thailand
7.7.6.1. Thailand market estimates and forecast, 2018 – 2030 (USD Million)
7.8. Latin America
7.8.1. Brazil
7.8.1.1. Brazil market estimates and forecast, 2018 – 2030 (USD Million)
7.8.2. Mexico
7.8.2.1. Mexico market estimates and forecast, 2018 – 2030 (USD Million)
7.8.3. Argentina
7.8.3.1. Argentina market estimates and forecast, 2018 – 2030 (USD Million)
7.9. MEA
7.9.1. South Africa
7.9.1.1. South Africa market estimates and forecast, 2018 – 2030 (USD Million)
7.9.2. Saudi Arabia
7.9.2.1. Saudi Arabia market estimates and forecast, 2018 – 2030 (USD Million)
7.9.3. UAE
7.9.3.1. UAE market estimates and forecast, 2018 – 2030 (USD Million)
7.9.4. Kuwait
7.9.4.1. Kuwait market estimates and forecast, 2018 – 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Innovators
8.3. Vendor Landscape
8.3.1. List of key distributors and channel partners
8.3.2. Key customers
8.3.3. Key company market share analysis, 2022
8.3.4. Abbott (St. Jude Medical)
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Usage benchmarking
8.3.4.4. Strategic initiatives
8.3.5. Medtronic
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Usage benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Boston Scientific Corporation
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Usage benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Aleva Neurotherapeutics S.A.
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Usage benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Nexstim
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Usage benchmarking
8.3.8.4. Strategic initiatives
8.3.9. LivaNova PLC
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Usage benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Neuropace Inc.
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Usage benchmarking
8.3.10.4. Strategic initiatives